-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-120-section-2-technical-specs.pdf
June 02, 2025 - CHIPRA 120 Section 2, Technical Specifications
A. Description
Reporting on the extent to which high risk women are delivered at facilities
with a 24/7 in-house physician capable of safely managing labor and
delivery, and performing a cesarean section, including an emerg…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-121-technicalspecs.pdf
June 02, 2025 - Technical Specifications: High-Risk Deliveries at Facilities with 24/7 In-House Physician Coverage Dedicated to the Obstetrical Service by an Anesthesiologist Who Is Qualified to Provide Obstetrical Anesthesia
A. Description
Reporting on the extent to which high risk women…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0123-technical-specifications.pdf
June 02, 2025 - CHIPRA 123: Technical Specifications
Section II: Detailed Measure Specifications
A. Description
Reporting on the extent to which high risk women are delivered at
facilities with level 3 or higher NICU services on campus according to
either American Academy of Pe…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-5-table-3.pdf
January 01, 2013 - Table 3. Evidence for Timely Bolus for Treatment of Children with Severe Sepsis of Septic Shock
Table 3: Evidence for Timely Fluid Bolus for Treatment of Children with Severe Sepsis or Septic
Shock
Type of
Evidence
Key Findings Level of
Evidence
(USPSTF
Ranking*)
Citations
Clinical
guidelines
Pe…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
April 01, 2012 - CVD
manifests typically as hypertension,
angina, myocardial infarction (MI),
heart failure, stroke … failure or other cardiovascular disease use dietary
supplementation and are thus placed at risk for … These included
exacerbation of congestive heart failure, number of
patients undergoing cardiac procedures … failure. … Lack of effect
of coenzyme Q on left ventricular function in patients with
congestive heart failure
-
hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-ChangeLog-v20231-v20241.xlsx
December 01, 2023 - DXCCSR ChangeLog v20221 v20231
Table_of_Contents
This Excel file enumerates the changes between the following releases of the Clinical Classifications Software Refined (CCSR) for ICD-10-CM diagnoses
Compared versions: v2024.1 (released December 2023) to v2023.1 (released November 2022)
Table of Contents
Changes t…
-
www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/care-coordination-slides.pptx
January 01, 2018 - Improving CC for CR Patients
Improving Support for Women Who Need Cardiac Rehabilitation
Enhancing Care for Heart … Failure Patients in Your CR Program
(Please read notes below to learn more about these materials)
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/sZN5HHS8w5Sar6bBPabsaB
June 01, 2008 - Angiotensin-receptor blockers pro-
vided significantly greater protection against congestive
heart failure … Rosiglitazone: new data on potential for increased risk for cardiac events
and heart failure. … failure (134) was noted recently. … the DM subgroup alone NR).
‡ Doxazosin treatment was prematurely discontinued because of an excess of heart … failure events.
§ P , 0.5 compared with chlorthalidone.
\ P value for interaction between DM and normoglycemia
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
June 15, 2008 - Angiotensin-receptor blockers provided significantly greater protection against congestive heart failure … An association between rosiglitazone and increased risk for myocardial infarction 134 , 137 and heart … failure 134 was noted recently. … Rosiglitazone: new data on potential for increased risk for cardiac events and heart failure. … c Doxazosin treatment was prematurely discontinued because of an excess of heart failure events.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
October 07, 2013 - nongeneralizable populations; patients with an existing cardiovascular disease diagnosis or history (heart … failure, previous stroke, previous MI, transient ischemic attack, angina, or previous bypass or angioplasty
-
digital.ahrq.gov/ahrq-funded-projects/evaluation-effectiveness-health-information-technology-based-care-transition/annual-summary/2012
January 01, 2012 - those managing at least two of the following chronic conditions: depression, diabetes, hypertension, heart … failure, chronic obstructive pulmonary disorder, coronary artery disease, transient ischemic attack,
-
www.ahrq.gov/diagnostic-safety/resources/issue-briefs/teledx-7.html
August 01, 2020 - Structured telephone support or non-invasive telemonitoring for patients with heart failure.
-
psnet.ahrq.gov/node/33584/psn-pdf
March 15, 2025 - Communication Between Clinicians
March 15, 2025
Communication Between Clinicians. PSNet [internet]. 2019.
https://psnet.ahrq.gov/primer/communication-between-clinicians
PSNet primers are regularly reviewed and updated by the UC Davis PSNet Editorial Team to ensure that
they reflect current research and practice in…
-
www.ahrq.gov/news/newsletters/e-newsletter/957.html
May 01, 2025 - Challenges related to out-of-pocket costs in heart failure management.
-
psnet.ahrq.gov/node/49713/psn-pdf
June 01, 2014 - CVC Removal: A Procedure Like Any Other
June 1, 2014
Feil M. CVC Removal: A Procedure Like Any Other. PSNet [internet]. 2014.
https://psnet.ahrq.gov/web-mm/cvc-removal-procedure-any-other
The Case
A 27-year-old man with a history of Behçet disease and recurrent liver abscesses was admitted to the
hospital for a p…
-
psnet.ahrq.gov/web-mm/sepsis-resulting-delays-treatment-and-miscommunication-among-specialists
February 26, 2025 - between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart … failure.
-
psnet.ahrq.gov/node/867497/psn-pdf
February 26, 2025 - Retained Surgical Items: Causation and Prevention
February 26, 2025
Gibbs V, Romano P. Retained Surgical Items: Causation and Prevention. PSNet [internet]. 2025.
https://psnet.ahrq.gov/primer/retained-surgical-items-causation-and-prevention
Background
A retained surgical item (RSI) is a surgical patient safety pro…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
February 01, 2016 - Pharmacotherapy for Adults With Alcohol Use
Disorder (AUD) in Outpatient Settings
Focus of This Summary
This is a summary of a systematic review evaluating the evidence regarding the efficacy, comparative effectiveness, and adverse effects
of medications in adults with alcohol use disorder (AUD). The systematic revi…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/b3a_combo_chartsforpresentations.xlsx
January 01, 2006 - infarction (AMI) mortality 0 0 0.0611616 58.783 -100 0 0.104046408 IQI 15 Significantly Lower *
IQI 16 Heart … failure mortality 0 0 0.0173928 31.98 -100 0 0.0543864916 IQI 16 Significantly Lower *
IQI 17 Acute
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/early-mobility-icu-slides.pptx
January 01, 2017 - Presentation: Program Overview
Early Mobility in the Intensive Care Unit
AHRQ Safety Program for Mechanically Ventilated Patients
AHRQ Pub. No. 16(17)-0018-15-EF
January 2017
Early Mobility in the ICU ‹#›
AHRQ Safety Program for Mechanically Ventilated Patients
1
Learning Objectives
After this session, you will…